Elucidation of Pathoptysiological Roles of Immune Chemokines
免疫趋化因子病理学作用的阐明
基本信息
- 批准号:11470091
- 负责人:
- 金额:$ 8万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1999
- 资助国家:日本
- 起止时间:1999 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The aim of the project has been to elucidate the pathophysiological roles of the immune chemokines, which are mainly directed to lymphocytes and dendritic cells. The main accomplishments of this year are as follows. (1) We showed that the proinflammatory cytokines such as IL-1 and TNFα potently induced normal human epidermal keratinocytes to express LARC/CCL20, the chemokine known to selectively attracts immature dendritic cells and α4β7-positive memory/effector T cells vua CCR6. We also showed that the lesional skin of atopic dermatitis (AD) often contained epidermal keratinocytes producing LARC and extensive accumulation of CCR6+ cells beneath the epidermal layer. Furthermore, we showed that plasma samples from AD patients often contained elevated levels of LARC. Collectively, these results support an important pathologenic role of LARC in AD. (2) We showed that expression of LARC was potently induced in mucosal epithelial cells by proinflammatory cytokines such as IL-1 and TNFα. Fur … More thermore, we analysed the activation mechanism of the LARC promoter by these cytokines and showed that an NF-kB site from -96 to -87bp from the transcriptional initiation site was essential for the induction of the LARC promoter. (3) We showed that TARC/CCL17 and MDC/CCL22, both known to attract Th2-type memory/effector T cells and skin-seeking CLA+ memory/effector T cells via CCR4, were significantly evevated in the plasma of AD patients. Furthermore, we found that platelets contained TARC and its contents were dramatically elevated in platelets from AD patients. We further showed that IFN-γinduced normal human epidermal keratinocytes to express TARC and MDC. Collectively, TARC and MDC may play important roles in the pathogenesis of AD. Furthermore, IFN-γ, which is also known to be apotent inducer of Th1-attracting chemokines, may be a critical factor in AD pathogenesis by inducing a set of chemokines attracting both Th1 and Th2 cells. (4) We showed that a large fraction of mature dendritic cells produced MDC and were clustered with CCR4-expressing T cesss in chronically inflamed skin infected with Candida albicans as well as in lymph node. Thus, MDC may play an important role in DC-T cell interactions. (5) We showed that in an asthmatic model in mice induced by priming with and subsequent inhalating of ovalbumin, the treatment with anti-mTARC monoclonal antibody efficiently blocked lung infiltrating of lymphocytes and eosinophils and elevation of methacholine-induced airway resistance. Thus, TARC is likely to play an important role in asthma. (6) We showed that in patients with multiple sclerosis (MS), the frequencies of lymphocytes expressing CCR5 or CXCR3 was increased in the cerebrospinal fluid during exacerbation, while the frequencies of CCR5-expressinglymphocytes were decreased after remission. These results support the Th1-biased immune responses in the pathogenesis of MS. (7) We generated monoclonal antibodies to mouse chemokines such as MDC, LARC and SLC/CCL21 in Armenisan hamsters but could not get antibodies with neutralizing activities. (8) We have repeatedly backcrossed TARC-knockout mice and αE integrin-knockout mice into BALB/c and C57BL/6 mice and developed the syngeneic strains. Less
该项目的目的是阐明免疫趋化因子的病理生理作用,主要针对淋巴细胞和树突状细胞。今年的主要成就如下:(1)我们证明了促炎细胞因子,例如IL-。 1 和 TNFα 有效诱导正常人表皮角质形成细胞表达 LARC/CCL20,该趋化因子已知可选择性吸引未成熟的树突状细胞并α4β7 阳性记忆/效应 T 细胞 vua CCR6 我们还表明,特应性皮炎 (AD) 的病变皮肤通常含有产生 LARC 的表皮角蛋白细胞,并且在表皮层下大量积聚 CCR6+ 细胞。 AD 患者的 LARC 水平通常升高。总的来说,这些结果支持 LARC 在 AD 中的重要致病作用 (2) 我们表明 LARC 的表达在 AD 中被有效诱导。此外,我们分析了这些细胞因子对 LARC 启动子的激活机制,并发现从转录起始位点起 -96 至 -87bp 的 NF-kB 位点。 (3) 我们发现 TARC/CCL17 和 MDC/CCL22 都已知能吸引 Th2 型记忆/效应子。 AD患者血浆中的T细胞和通过CCR4寻找皮肤的CLA+记忆/效应T细胞显着升高。此外,我们发现AD患者的血小板中含有TARC,并且其含量显着升高。 -γ诱导正常人表皮角蛋白表达TARC和MDC,此外,TARC和MDC可能在AD的发病机制中发挥重要作用。 (4)我们发现,在感染白色念珠菌的慢性发炎皮肤以及淋巴结中,大部分成熟树突状细胞产生MDC,并与表达CCR4的T细胞聚集在一起,因此,MDC可能在DC-中发挥重要作用。 T 细胞相互作用。 (5) 我们发现,在通过启动并随后吸入卵清蛋白诱导的小鼠哮喘模型中,用抗 mTARC 单克隆抗体治疗可有效阻止淋巴细胞和嗜酸性粒细胞的肺部浸润以及醋甲胆碱诱导的气道阻力的升高。 (6) 我们发现,在多发性硬化症 (MS) 患者中,表达 CCR5 或 CXCR3 的淋巴细胞的频率较低。恶化期间脑脊液中表达 CCR5 的淋巴细胞的频率增加,而缓解后这些结果支持 MS 发病机制中的 Th1 偏向免疫反应 (7) 我们生成了针对小鼠趋化因子(如 MDC、LARC)的单克隆抗体。和亚美尼亚仓鼠中的SLC/CCL21,但无法获得具有中和活性的抗体(8)我们多次回交TARC敲除。将小鼠和 αE 整合素敲除小鼠转化为 BALB/c 和 C57BL/6 小鼠,并开发出同系品系 Less。
项目成果
期刊论文数量(113)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Terada, N., et al.: "The kinetics of allergen induced eotawin level in nasal lavage fluid : its key role in eosinophil recruitment in nasal mucosa"American Journal of Respiratory and Critical Care Medicine. 164-4. 575-579 (2001)
Terada, N. 等人:“鼻腔灌洗液中过敏原诱导的嗜酸性粒细胞水平的动力学:其在鼻粘膜中嗜酸性粒细胞募集中的关键作用”美国呼吸与重症监护医学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Katou, F., et al.: "Macrophage-derived chemokine (MDC/CCL22) and CCR4 are involved in the formation of T lymphocyte dendritic clusters in human inflamed skin and secondary lymphoid tissue"American Journal of Pathology. 158-2. 1263-1270 (2001)
Katou, F., 等人:“巨噬细胞衍生的趋化因子 (MDC/CCL22) 和 CCR4 参与人类发炎皮肤和次级淋巴组织中 T 淋巴细胞树突状簇的形成”美国病理学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nomiyama, H., et al.: "Organization of the chomokine genes in the human and mouse major clusters of CC and CXC chomokinos diversification between the two species"Genes and Immunity. 2. 110-113 (2001)
Nomiyama, H. 等人:“人类和小鼠主要 CC 和 CXC chomokinos 簇中两个物种之间的 chomokinos 多样化的组织”基因与免疫。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yoshida, T., et al.: "Molecular cloning of mXCR1, the murine SCM-1/lymphotactin receptor"FEBS Letters. 458. 37-40 (1999)
Yoshida, T. 等人:“小鼠 SCM-1/淋巴趋化素受体 mXCR1 的分子克隆”FEBS Letters。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Misu, T., et al.: "Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis : imbalance of Th1/Th2 -associated chemokine signaling"Journal of Nouroimmunology. 114. 207-212 (2001)
Misu,T.,等人:“多发性硬化症复发和缓解时血液和脑脊液中 T 细胞上的趋化因子受体表达:Th1/Th2 相关趋化因子信号传导的不平衡”《神经免疫学杂志》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOSHIE Osamu其他文献
A CC3 variant of lymphotactin/XCL1 (XCL1-CC3) functions as a potent adjuvant to accumulate CD103+XCR1+ cross-presenting dendritic cells and induce antigen-specific CD8+ T cell responses
淋巴趋化素/XCL1 (XCL1-CC3) 的 CC3 变体可作为有效佐剂积聚 CD103 XCR1 交叉呈递树突状细胞并诱导抗原特异性 CD8 T 细胞应答
- DOI:
- 发表时间:
2016 - 期刊:
- 影响因子:0
- 作者:
YAMAMOTO Shinya;MATSUO Kazuhiko;YOSHIE Osamu;NAKAYAMA Takashi - 通讯作者:
NAKAYAMA Takashi
YOSHIE Osamu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOSHIE Osamu', 18)}}的其他基金
Learning support mechanism based on analysis of consensus building among users
基于用户共识分析的学习支持机制
- 批准号:
15K00495 - 财政年份:2015
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of CCL28 for mucosal immunity
CCL28 对粘膜免疫的作用
- 批准号:
26460582 - 财政年份:2014
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Transcriptional regulation of CCR7 expression in mature T-cell malignancies
成熟 T 细胞恶性肿瘤中 CCR7 表达的转录调控
- 批准号:
23501273 - 财政年份:2011
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on the pathophysiological role of the Th2-type chemokine receptor CCR4
Th2型趋化因子受体CCR4的病理生理作用研究
- 批准号:
19390277 - 财政年份:2007
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Transcriptional regulation of CCR10 expression in plasma cells
浆细胞中 CCR10 表达的转录调控
- 批准号:
17590443 - 财政年份:2005
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on growth and differentiation of human eosinophils
人嗜酸性粒细胞生长和分化的研究
- 批准号:
62570532 - 财政年份:1987
- 资助金额:
$ 8万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
非典型趋化因子受体1阳性内皮细胞通过TRAIL-DR5调节BMSC成骨成脂分化及其机制
- 批准号:82370886
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
趋化因子受体CXCL8-CXCR1通过PI3K/AKT信号通路调控引导内源性大块软骨再生过程的机制研究
- 批准号:82372546
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
趋化因子受体CCR1的偏向性信号转导在哮喘发生中的作用和分子机制研究
- 批准号:82300026
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
血浆外泌体调控细胞CXC趋化因子及其受体参与结核病发生发展的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:32 万元
- 项目类别:地区科学基金项目
趋化因子受体CCR8的结构生物学研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
Unconventional IL-1 signaling in heart failure
心力衰竭中的非常规 IL-1 信号传导
- 批准号:
10560648 - 财政年份:2020
- 资助金额:
$ 8万 - 项目类别:
Unconventional IL-1 signaling in heart failure
心力衰竭中的非常规 IL-1 信号传导
- 批准号:
10356119 - 财政年份:2020
- 资助金额:
$ 8万 - 项目类别:
Unconventional IL-1 Signaling in Heart failure
心力衰竭中的非常规 IL-1 信号传导
- 批准号:
10829159 - 财政年份:2020
- 资助金额:
$ 8万 - 项目类别:
Lymphocyte and inflammatory cytokine markers of response in the first-in-human combination of anti-PD-1 mAb and IL-15/IL-15Ra complexes and investigation of mediators of anti-tumor immune responses
抗 PD-1 mAb 和 IL-15/IL-15Ra 复合物的首次人体组合反应中的淋巴细胞和炎症细胞因子标记物以及抗肿瘤免疫反应介质的研究
- 批准号:
10374802 - 财政年份:2019
- 资助金额:
$ 8万 - 项目类别:
Lymphocyte and inflammatory cytokine markers of response in the first-in-human combination of anti-PD-1 mAb and IL-15/IL-15Ra complexes and investigation of mediators of anti-tumor immune responses
抗 PD-1 mAb 和 IL-15/IL-15Ra 复合物的首次人体组合反应中的淋巴细胞和炎症细胞因子标记物以及抗肿瘤免疫反应介质的研究
- 批准号:
9902376 - 财政年份:2019
- 资助金额:
$ 8万 - 项目类别: